Latham & Watkins LLP covers the full range of ECM matters based on an integrated corporate finance approach that includes transactions in relation to DCM, restructuring as well as banking and finance. The group has particular expertise in advising on alternative forms of equity financing and assisting German issuers with IPOs in the US. Practice head Oliver Seiler is experienced in IPOs, block trades and capital increases. International public takeovers, carve-outs and transactions represent David Rath's mainstays. Associate Camilla Kehler-Weiß is another key contact and covers the ECM area comprehensively.
Testimonials
Collated independently by Legal 500 research team.
'Team with great legal expertise in the ECM/capital markets business, which has built an outstanding track record of high-profile ECM deals in recent years. In addition to its legal skills, the project management skills and high level of commitment are also convincing.'
'Oliver Seiler is an outstanding lawyer with a wealth of experience. In recent years he and his team have been involved in many high-profile transactions. He impresses not only with his high level of professional competence, but also with his pragmatic approach and his pleasant manner. He has build up David Rath as a younger partner, who had already impressed as a senior associate and now ensures that the team has sufficient resources and appropriate seniority at all times.'
'Camilla Kehler-Weiß, who leads the overall very strong team of associates, also does excellent work.'
Key clients
- Bank of America Merrill Lynch
- Barclays
- Cheplapharm AG
- Citigroup
- Commerzbank AG
- Credit Suisse
- Deutsche Bank
- Goldman Sachs
- J.P. Morgan Chase
- Morgan Stanley
Work highlights
- Advising CHEPLAPHARM AG, a leading international platform for established branded medicines, on the agreement for a structured investment with global investment firms Atlantic Park and GIC with a total volume of €550 million.
- Advising the banking consortium on a cash capital increase of TUI AG with subscription rights from authorized capital, which generated gross proceeds of approximately €1.8 billion.
- Advising the banking consortium on the planned carve-out and subsequent IPO on the Frankfurt Stock Exchange of thyssenkrupp Nucera (formerly Uhde Chlorine Engineers).
Lawyers
Practice head
The lawyer(s) leading their teams.
Oliver Seiler